Materialise NV engages in the provision of additive manufacturing software and 3D printing services. It operates through the following segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software worldwide through programs and platforms that enable companies to set up reliable and sustainable 3D printing production. The Materialise Medical segment includes medical software solutions, medical devices and other related products and services. The Materialise Manufacturing segment provides 3D printed services to industrial and commercial customers. The company was founded by Wilfried Vancraen and Hilde Ingelaere on June 28, 1990 and is headquartered in Leuven, Belgium.
相关临床试验
6
3 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
Enrolling By Invitation
1
16.7%
尚未招募
2
33.3%
招募中
1
16.7%
终止
2
33.3%
暂无批准数据
- The global 3D printing medical devices market is projected to grow from USD 3.71 billion in 2025 to USD 18.61 billion by 2035, at a CAGR of 17.49%. - Key drivers include rising demand for patient-specific implants and prosthetics, increased use of surgical guides and anatomical models, and advances in biocompatible materials. - Major players such as Stratasys, 3D Systems, and Materialise are launching new multi-material and workflow automation technologies to expand clinical applications. - Technologies including selective laser sintering, bioprinting, and AI-powered design software are enabling better patient outcomes at reduced costs and faster treatment times.
- Michigan Medicine and Materialise initiate an eight-year clinical trial to evaluate 3D-printed bioresorbable airway splints for treating severe tracheobronchomalacia in infants, marking a crucial step toward FDA approval. - The groundbreaking device, successfully used in over 40 emergency cases at U-M Health Mott Children's Hospital, is designed to grow with patients and safely dissolve over time. - The multi-center trial aims to enroll 35 infants across five children's hospitals, with Materialise manufacturing the customized devices at their Ann Arbor facility.
